Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1
Neurodegenerative Diseases · 2018 · 18 (2-3) · 57-68
DOI: 10.1159/000485899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurodegenerative Diseases, online erschienen am 22.02.2018. Verfasst von Hannes O Tiedt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Berlin, Germany. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
In rare cases, patients with Alzheimer disease (AD) present at an early age and with a family history suggestive of an autosomal dominant mode of inheritance. Mutations of the presenilin-1 (PSEN1) gene are the most common causes of dementia in these patients. Early-onset and particularly familial AD patients frequently present with variable non-amnestic cognitive symptoms such as visual, language or behavioural changes as well as non-cognitive, e.g. motor, symptoms.
Objective
To investigate the phenotypic variability in carriers of the PSEN1 S170F mutation.
Methods
We report a family with 4 patients carrying the S170F mutation of whom 2 underwent detailed clinical examinations. We discuss our current findings in the context of previously reported S170F cases.
Results
The clinical phenotype was consistent regarding initial memory impairment and early onset in the late twenties found in all S170F patients. There were frequent non-amnestic cognitive changes and, at early stages of the disease, indications of a more pronounced disturbance of visuospatial abilities as compared to face and object recognition. Non-cognitive symptoms most often included myoclonus and cerebellar ataxia. A review of the available case reports indicates some phenotypic variability associated with the S170F mutation including different constellations of symptoms such as parkinsonism and delusions.
Conclusion
The variable clinical findings associated with the S170F mutation highlight the relevance of atypical phenotypes in the context of research and under a clinical perspective. CSF sampling and detection of Aβ species may be essential to indicate AD pathology in unclear cases presenting with cognitive and motor symptoms at a younger age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Berlin, Germany.
Zitieren
APA
Tiedt, H. O., Benjamin, B., Niedeggen, M., & Lueschow, A. (2018). Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1. Neurodegenerative Diseases, 18(2-3), 57-68. https://doi.org/10.1159/000485899
Vancouver
Tiedt HO, Benjamin B, Niedeggen M, Lueschow A. Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1. Neurodegenerative Diseases. 2018;18(2-3):57-68. doi:10.1159/000485899
BibTeX
@article{Tiedt2018,
author = {Tiedt, Hannes O and Benjamin, Beate and Niedeggen, Michael and Lueschow, Andreas},
title = {Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1},
journal = {Neurodegenerative Diseases},
year = {2018},
volume = {18},
number = {2-3},
pages = {57--68},
doi = {10.1159/000485899}
}
EUVIMED